Laboratory Grade GS-441524 Tablets 20mg 40mg 50mg 60mg Oral Veterinary Formula for Cat FIP

GS-441524 oral tablets are developed for veterinary use in feline infectious peritonitis (FIP) management. Designed for convenient oral administration, they provide a practical option for cats requiring ongoing antiviral treatment. The tablet formulation is easy to store, simple to administer, and suitable for daily use as part of a veterinarian-directed care plan.

To meet the needs of different cats and treatment protocols, the product is offered in 20mg, 40mg, 50mg, and 60mg tablet strengths. The availability of multiple dosage options allows more precise adjustment according to body weight and clinical progression while improving dosing flexibility throughout the treatment period.

Each batch is manufactured using controlled production procedures and undergoes routine quality inspections to support consistent product quality and reliable performance.

Different treatment stages and body weights often require different tablet strengths. Providing several dosage options allows veterinary professionals to create more individualized treatment plans.

Available strengths include:

• 20mg – Suitable for kittens and smaller cats or fine dosage adjustments.
• 40mg – Frequently selected for standard daily treatment programs.
• 50mg – Helps reduce the number of tablets needed for medium-weight cats.
• 60mg – Designed for cats requiring higher daily antiviral intake.

The tablet format offers an alternative to injections and may be easier for owners to administer during extended treatment periods. It can also simplify daily medication routines.

From ingredient selection to final packaging, production follows standardized quality management procedures to help ensure consistency between batches.

Protective packaging helps preserve tablet quality during shipping, storage, and routine handling while supporting long-term product stability.

FIP is a serious viral disease that develops after feline coronavirus (FCoV) mutates inside the body. Although coronavirus infection is relatively common in cats, only a small number progress to FIP.

The disease may appear in several forms depending on the organs affected:

• Wet FIP – Characterized by fluid accumulation in the abdominal or chest cavity.
• Dry FIP – Primarily affects internal organs without significant fluid buildup.
• Ocular FIP – May cause inflammation involving the eyes.
• Neurological FIP – Can affect the brain and nervous system, leading to neurological symptoms.

Because each cat responds differently, treatment plans should be determined through veterinary evaluation and adjusted according to ongoing clinical monitoring.

GS-441524 tablets are commonly supplied for use in:

• Veterinary clinics
• Animal hospitals
• Cat rescue organizations
• Professional breeding facilities
• Veterinary medicine distributors
• Home care under veterinary supervision

The combination of multiple tablet strengths provides flexibility for different stages of FIP management and varying patient needs.

For optimal product quality:

• Store at room temperature in a dry environment.
• Keep the container tightly closed after opening.
• Avoid direct sunlight and excessive humidity.
• Do not expose the product to high temperatures for extended periods.

Proper storage conditions help maintain tablet quality throughout the product shelf life.

Every production lot undergoes quality control before release. Manufacturing records, batch numbers, and traceability systems are maintained to support consistent production standards and dependable supply.

With multiple strength options, stable manufacturing quality, and convenient oral administration, GS-441524 tablets are suitable for veterinary professionals and distributors seeking reliable products for feline healthcare.

This product is intended exclusively for veterinary use.

The selection of tablet strength, dosage schedule, and treatment duration should be based on veterinary assessment, body weight, and the individual health condition of the cat.